DK1729777T3 - Farmaceutisk sammensætning omfattende et mirtazapinsalat - Google Patents

Farmaceutisk sammensætning omfattende et mirtazapinsalat

Info

Publication number
DK1729777T3
DK1729777T3 DK05740221T DK05740221T DK1729777T3 DK 1729777 T3 DK1729777 T3 DK 1729777T3 DK 05740221 T DK05740221 T DK 05740221T DK 05740221 T DK05740221 T DK 05740221T DK 1729777 T3 DK1729777 T3 DK 1729777T3
Authority
DK
Denmark
Prior art keywords
mirtazapine
salad
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK05740221T
Other languages
Danish (da)
English (en)
Inventor
Sytske Hyke Moolenaar
Gerardus Johannes Kemperman
Der Voort Maarschalk Kees Van
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK1729777T3 publication Critical patent/DK1729777T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK05740221T 2004-04-21 2005-04-19 Farmaceutisk sammensætning omfattende et mirtazapinsalat DK1729777T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101664 2004-04-21
PCT/EP2005/051714 WO2005102352A1 (en) 2004-04-21 2005-04-19 Pharmaceutical composition comprising a salt of mirtazapine

Publications (1)

Publication Number Publication Date
DK1729777T3 true DK1729777T3 (da) 2009-06-08

Family

ID=34928990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05740221T DK1729777T3 (da) 2004-04-21 2005-04-19 Farmaceutisk sammensætning omfattende et mirtazapinsalat

Country Status (31)

Country Link
US (1) US20070111993A1 (he)
EP (1) EP1729777B1 (he)
JP (2) JP5260959B2 (he)
CN (2) CN1942191B (he)
AR (1) AR049028A1 (he)
AT (1) ATE424210T1 (he)
AU (1) AU2005235383B2 (he)
BR (1) BRPI0509953A (he)
CA (1) CA2561281C (he)
CY (1) CY1109018T1 (he)
DE (1) DE602005013066D1 (he)
DK (1) DK1729777T3 (he)
EC (1) ECSP066938A (he)
ES (1) ES2321961T3 (he)
HR (1) HRP20090190T1 (he)
IL (1) IL178201A (he)
LV (1) LV13556B (he)
MX (1) MXPA06011830A (he)
MY (1) MY144899A (he)
NO (1) NO20065077L (he)
NZ (1) NZ550052A (he)
PE (1) PE20060400A1 (he)
PL (1) PL1729777T3 (he)
PT (1) PT1729777E (he)
RS (1) RS50764B (he)
RU (1) RU2375362C2 (he)
SI (1) SI1729777T1 (he)
TW (1) TW200538100A (he)
UA (1) UA89773C2 (he)
WO (1) WO2005102352A1 (he)
ZA (1) ZA200608305B (he)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) * 1976-07-27 1980-03-18 Fiber Materials, Inc. Method of forming carbon composites
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
PT1067934E (pt) * 1998-04-02 2004-03-31 Akzo Nobel Nv Solucao anti-depressiva liquida oral
WO2001000196A2 (en) * 1999-06-25 2001-01-04 University Of South Florida Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
KR20020086945A (ko) * 2000-04-05 2002-11-20 악조 노벨 엔.브이. 비스테로이드성 항염증제를 포함하는 두통 치료용 약제조합물

Also Published As

Publication number Publication date
EP1729777A1 (en) 2006-12-13
CA2561281A1 (en) 2005-11-03
MXPA06011830A (es) 2007-03-23
JP2013136626A (ja) 2013-07-11
CN1942191B (zh) 2011-02-02
ZA200608305B (en) 2008-08-27
MY144899A (en) 2011-11-30
UA89773C2 (ru) 2010-03-10
CY1109018T1 (el) 2014-07-02
CA2561281C (en) 2013-04-02
HRP20090190T1 (en) 2009-05-31
IL178201A (he) 2010-06-30
CN101824035A (zh) 2010-09-08
SI1729777T1 (sl) 2009-08-31
PL1729777T3 (pl) 2009-07-31
JP2007533705A (ja) 2007-11-22
AU2005235383B2 (en) 2010-05-27
AR049028A1 (es) 2006-06-21
ECSP066938A (es) 2006-12-20
US20070111993A1 (en) 2007-05-17
CN1942191A (zh) 2007-04-04
DE602005013066D1 (de) 2009-04-16
PT1729777E (pt) 2009-04-27
LV13556B (en) 2007-07-20
BRPI0509953A (pt) 2007-09-25
RU2006140988A (ru) 2008-05-27
AU2005235383A1 (en) 2005-11-03
JP5260959B2 (ja) 2013-08-14
RS50764B (sr) 2010-08-31
RU2375362C2 (ru) 2009-12-10
NZ550052A (en) 2010-02-26
ATE424210T1 (de) 2009-03-15
NO20065077L (no) 2006-11-14
ES2321961T3 (es) 2009-06-15
PE20060400A1 (es) 2006-05-27
TW200538100A (en) 2005-12-01
WO2005102352A1 (en) 2005-11-03
EP1729777B1 (en) 2009-03-04
IL178201A0 (en) 2006-12-31

Similar Documents

Publication Publication Date Title
BRPI0511900A (pt) composições farmacêuticas
DK2783682T3 (da) Farmaceutisk sammensætning omfattende pimobendan
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
DE602005026188D1 (de) Medikamentenspender
NO20075628L (no) Farmasøytiske formuleringer
DK1957073T3 (da) Lægemiddel
ITMI20041252A1 (it) Composizioni perfluoroelastomeriche
DE602005020716D1 (de) Fluoroelastomere
DE602005016978D1 (de) Quecksilberfreisetzende Zusammensetzungen
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
MA28801B1 (fr) Composition antihistaminique
DK2918286T3 (da) En farmaceutisk formulering
DK1729777T3 (da) Farmaceutisk sammensætning omfattende et mirtazapinsalat
DE602005008045D1 (de) Werbehilfe
ITMI20042232A1 (it) Composizione farmaceutica contenente clozapina
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
DK1753431T3 (da) Farmaceutisk sammensætning omfattende ZD6474
NO20042027L (no) Oral composition
FI20041361A (fi) Pakkausmateriaalit
NO20045094D0 (no) Emballasje
ES1059039Y (es) Expositor modular
FR2871918B1 (fr) Enseigne modulaire
ES1062686Y (es) Expositor modular
ITMI20040621A1 (it) Composizioni farmaceutiche orali